Another gene of interest is Adcyap1r1, as it codes for a protein that potentiates insulin secretion and has been considered as a potential T2D therapeutic option (Filipsson et al. 1999; Inagaki et al. 1996; Liu et al. 2019; Marzagalli et al. The gene discussed is INS; the disease is type 2 diabetes mellitus.